Use of Central Pharmacies for Direct to Patient in your Clinical Supply Chain (WS4)
- Date:
- 30 April 2018
- Time:
- -
- Available Seats:
- 50
The attendee will be able to:
- Describe two (2) benefits each for the clinical site, sponsor and patient of a direct to patient trial.
- Identify at least two (2) risks for sponsors conducting direct to patient trials and develop effective mitigation strategies for these risks.
- Identify how use of Central Pharmacies can support delivery of medication closer to the patient thus minimizing waste.
